This study utilizes transfer learning with CNNs to classify fungal genera and identify Aspergillus species using microscopic images from touch-tape preparation and lactophenol cotton blue staining....

Some institutions have reported changes in Candida species distribution alongside an increase in antifungal resistance rates in recent years, mainly because of the emergence of Candida auris or...

A bloodstream infection is a life-threatening condition. Rapid reporting of actionable microbiological results is critical for patient management. Delays i

Cryptococcosis is a major worldwide disseminated invasive fungal infection. Cryptococcosis, particularly in its most lethal manifestation of cryptococcal meningitis, accounts for substantial mortal...

Nature Microbiology - Phylogenetics and convergence-based genome-wide association studies were used to analyse genomic variants across approximately 2,000 isolates from six Candida species to...

PDF | Candida auris has become a major health threat due to its transmissibility, multidrug resistance and severe outcomes. In a case-control design, 74... | Find, read and cite all the research you...

Cases of Candida auris have increased every year since 2016. Experts say it's only a matter of time before they're reported in every state.

Nature Microbiology - The agrochemical fungicide ipflufenoquin can drive cross-resistance to the clinical antifungal olorofim in Aspergillus fumigatus in vitro.

Gene Therapy - Preclinical safety and biodistribution of CRISPR targeting SIV in non-human primates

Resistance to fluconazole (FLC), the most widely used antifungal drug, is typically achieved by altering the azole drug target and/or drug efflux pumps. Recent reports have suggested a link between...

Approval based on positive results from the pivotal ReSTORE Phase III clinical trial and supported by the STRIVE Phase II clinical trials and extensive nonclinical development program. REZZAYO...

– REZZAYO is a novel, once-weekly, next-generation echinocandin indicated for the treatment of candidemia and invasive candidiasis in adults with limited or no alternative treatment options – –...

CRESEMBA is the only azole antifungal therapy approved for pediatric patients as young as one affected by these serious, potentially life-threatening infections Approval based on results of two...

PDF | Invasive fungal infections, which kill more than 1.6 million patients each year worldwide, are difficult to treat due to the limited number of... | Find, read and cite all the research you need...